Post Profile

Prostate Cancer Treatment Can Raise Dementia Risk

Reducing testosterone levels with androgen deprivation therapy, or A.D.T., more than doubles the risk of dementia.
read more


Related Posts

Shorter Course of Androgen Deprivation Therapy for High-Risk Prostate Cancer Patients Yields Improved Quality of Life

Health : Newswise Medical News

High-risk prostate cancer patients who receive radiation therapy (RT) and an 18-month course of androgen deprivation therapy (ADT) recover a normal testosterone level in a shorter amount of time compared to those who receive a 36-mo...

Prostate Cancer - Androgen Deprivation Therapy Does Not Raise Cardiovascular Death Risk

Health : Medical News Today

A study published in the December issue of JAMA shows that even though earlier investigations suggested that androgen deprivation therapy designed to inhibit the production of male sex hormones for the treatment of prostate cancer m...

Medical News Today: Hormone therapy for prostate cancer may raise dementia risk

Health : Medical News Today

Men treated with androgen deprivation therapy - a hormone therapy - for prostate cancer may be more than twice as likely to develop dementia, study finds.

Common Prostate Cancer Treatment Tied to Dementia

Health : Newswise Medical News

Androgen Deprivation Therapy, a common hormone therapy to treat prostate cancer, may double a man's risk of dementia, regardless of his age, Penn Medicine researchers reported.

Prostate Cancer Treatment Linked to Dementia

Mental Health / Alzheimer's : Alzheimer's Reading Room

Men being treated with prostate cancer therapies that reduce their testosterone levels are at greater risk of developing dementia within five years. Reducing testosterone levels with androgen deprivation therapy (ADT) is a common tr...


Copyright © 2016 Regator, LLC